Chemical Compound Review:
CHEMBL438194 (3S)-3-[[(2S)-2-[[(2R)-2- acetamido-3-(4...
Synonyms:
CHEBI:240374, PD-142893, AC1L3U2Y, PD 142893, 143037-36-9, ...
- Endothelin-1 does not contribute to ischemia/reperfusion-induced vasoconstriction in skeletal muscle. Wang, W.Z., Anderson, G., Acland, R.D., Barker, J. Journal of reconstructive microsurgery. (1997)
- Growth inhibitory properties of endothelin-1 in human hepatic myofibroblastic Ito cells. An endothelin B receptor-mediated pathway. Mallat, A., Fouassier, L., Préaux, A.M., Gal, C.S., Raufaste, D., Rosenbaum, J., Dhumeaux, D., Jouneaux, C., Mavier, P., Lotersztajn, S. J. Clin. Invest. (1995)
- Protein kinase C and protein tyrosine kinase activity contribute to mitogenic signaling by endothelin-1. Cross-talk between G protein-coupled receptors and pp60c-src. Simonson, M.S., Herman, W.H. J. Biol. Chem. (1993)
- EndothelinB receptor activation enhances parathyroid hormone-induced calcium signals in UMR-106 cells. Lee, S.K., Stern, P.H. J. Bone Miner. Res. (1995)
- Characterization of endothelin receptors in mesangial cells: evidence for two functionally distinct endothelin binding sites. Simonson, M.S., Rooney, A. Mol. Pharmacol. (1994)
- Physiological concentrations of insulin induce endothelin-mediated vasoconstriction during inhibition of NOS or PI3-kinase in skeletal muscle arterioles. Eringa, E.C., Stehouwer, C.D., Merlijn, T., Westerhof, N., Sipkema, P. Cardiovasc. Res. (2002)
- Structure-activity relationships of the potent combined endothelin-A/endothelin-B receptor antagonist Ac-DDip16-Leu-Asp-Ile-Ile-Trp21: development of endothelin-B receptor selective antagonists. Cody, W.L., He, J.X., DePue, P.L., Waite, L.A., Leonard, D.M., Sefler, A.M., Kaltenbronn, J.S., Haleen, S.J., Walker, D.M., Flynn, M.A. J. Med. Chem. (1995)
- Toward the rational development of peptidomimetic analogs of the C-terminal endothelin hexapeptide: development of a theoretical model. Macchia, M., Barontini, S., Ceccarelli, F., Galoppini, C., Giusti, L., Hamdan, M., Lucacchini, A., Martinelli, A., Menchini, E., Mazzoni, M.R., Revoltella, R.P., Romagnoli, F., Rovero, P. Farmaco (1998)
- Role of matrix metalloproteinase-2 in thrombin-induced vasorelaxation of rat mesenteric arteries. Fernandez-Patron, C., Radomski, M.W., Davidge, S.T. Am. J. Physiol. Heart Circ. Physiol. (2000)
- Use of the endothelin antagonists BQ-123 and PD 142893 to reveal three endothelin receptors mediating smooth muscle contraction and the release of EDRF. Warner, T.D., Allcock, G.H., Corder, R., Vane, J.R. Br. J. Pharmacol. (1993)
- Comparative studies with the endothelin receptor antagonists BQ-123 and PD 142893 indicate at least three endothelin receptors. Warner, T.D., Allcock, G.H., Mickley, E.J., Corder, R., Vane, J.R. J. Cardiovasc. Pharmacol. (1993)
- Characterization of the potent combined endothelin(A/B)-antagonist PD 142893 on cerebral vessels. Zimmermann, M., Vatter, H., Weyrauch, E., Lange, B.N., Krishnan, R., Raabe, A., Seifert, V. Neurol. Res. (2004)
- Role of endothelin, nitric oxide and L-arginine release in ischaemia/reperfusion injury of rat heart. Brunner, F., Leonhard, B., Kukovetz, W.R., Mayer, B. Cardiovasc. Res. (1997)
- Subtypes of endothelin receptors that mediate venous effects of endothelin-1 in anaesthetized rats. Palacios, B., Lim, S.L., Pang, C.C. Br. J. Pharmacol. (1997)
- PD 142893, SB 209670, and BQ 788 selectively antagonize vascular endothelial versus vascular smooth muscle ET(B)-receptor activity in the rat. Schroeder, R.L., Keiser, J.A., Cheng, X.M., Haleen, S.J. J. Cardiovasc. Pharmacol. (1998)
- Effects of endothelin receptor antagonists on bradykinin-induced increases in macromolecular efflux. Mayhan, W.G., Rubinstein, I. Inflammation (1994)
- Nonpeptide endothelin receptor antagonists. VI: Pharmacological characterization of SB 217242, a potent and highly bioavailable endothelin receptor antagonist. Ohlstein, E.H., Nambi, P., Lago, A., Hay, D.W., Beck, G., Fong, K.L., Eddy, E.P., Smith, P., Ellens, H., Elliott, J.D. J. Pharmacol. Exp. Ther. (1996)
- Amelioration of cyclosporin A effect on microvasculature by endothelin inhibitor. Wilasrusmee, C., Ondocin, P., Bruch, D., Shah, G., Kittur, S., Wilasrusmee, S., Kittur, D.S. Surgery (2003)
- Pharmacological differences between rat and human endothelin B receptors. Reynolds, E.E., Hwang, O., Flynn, M.A., Welch, K.M., Cody, W.L., Steinbaugh, B., He, J.X., Chung, F.Z., Doherty, A.M. Biochem. Biophys. Res. Commun. (1995)